NYLIM U.S. Large Cap R&D Leaders ETF (LRND)

The most compelling signal here is the powerful multi-year momentum: the fund has delivered a +103.47% cumulative return over the last three years, driven by three consecutive years of positive annual growth (+33%, +30%, +17%). This trajectory suggests the underlying R&D leaders portfolio is successfully capturing innovation trends, justifying a solid long-term buy rating despite the elevated 30x P/E, which reflects the premium for high-growth tech exposure. However, the short-term outlook shows signs of cooling; after hitting a 52-week high near $49.30, the price has retreated to the mid-$40s, trading below its 50-day moving average. While the 45-day statistical model offers a modest bullish lean, the recent price action indicates some profit-taking or mean reversion. Consequently, while the business quality remains strong, the immediate entry point feels less urgent than it was a few months ago, warranting a slightly cautious near-term stance. On the income side, the yield is negligible at 0.31%, offering no meaningful cushion against volatility or inflation, confirming this is purely a growth vehicle.